https://www.atricure.com/news-former en https://ir.atricure.com/news-releases/news-release-details/atricure-reports-first-quarter-2021-financial-results MASON, Ohio --(BUSINESS WIRE)--Apr. 27, 2021-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2021 financial results. “Our growth in the first quarter is a testament of our Tue, 27 Apr 2021 20:01:00 +0000 AtriCure, Inc. News Releases 15356 https://ir.atricure.com/news-releases/news-release-details/atricure-names-b-kristine-johnson-board-chair MASON, Ohio --(BUSINESS WIRE)--Apr. 8, 2021-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that B. Kristine (Kris) Johnson has been named Board Chair. Thu, 08 Apr 2021 12:00:00 +0000 AtriCure, Inc. News Releases 15331 https://ir.atricure.com/news-releases/news-release-details/atricure-announce-first-quarter-2021-financial-results MASON, Ohio --(BUSINESS WIRE)--Apr. 6, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its first quarter 2021 financial results on Tuesday, April 27, 2021 . Tue, 06 Apr 2021 12:00:00 +0000 AtriCure, Inc. News Releases 15321 https://ir.atricure.com/news-releases/news-release-details/atricure-participate-oppenheimer-31st-annual-healthcare MASON, Ohio --(BUSINESS WIRE)--Mar. 2, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming Oppenheimer 31 st Annual Tue, 02 Mar 2021 21:01:00 +0000 AtriCure, Inc. News Releases 15271 https://ir.atricure.com/news-releases/news-release-details/atricure-reports-fourth-quarter-2020-and-full-year-2020 MASON, Ohio --(BUSINESS WIRE)--Feb. 23, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced fourth quarter 2020 and full year 2020 financial results. Tue, 23 Feb 2021 21:01:00 +0000 AtriCure, Inc. News Releases 15246 https://ir.atricure.com/news-releases/news-release-details/atricure-participate-svb-leerink-10th-annual-global-healthcare MASON, Ohio --(BUSINESS WIRE)--Feb. 10, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming SVB Leerink 10 th Annual Wed, 10 Feb 2021 13:00:00 +0000 AtriCure, Inc. News Releases 15201 https://ir.atricure.com/news-releases/news-release-details/atricure-announce-fourth-quarter-and-full-year-2020-financial MASON, Ohio --(BUSINESS WIRE)--Feb. 2, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its fourth quarter and full year 2020 financial results on Tuesday, Tue, 02 Feb 2021 13:00:00 +0000 AtriCure, Inc. News Releases 15171 https://ir.atricure.com/news-releases/news-release-details/atricure-reports-preliminary-results-fourth-quarter-and-full-2 Fourth quarter 2020 worldwide revenue of $57.7 million ( U.S.   $47.4 million , International $10.3 million ) MASON, Ohio --(BUSINESS WIRE)--Jan. 11, 2021-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, Mon, 11 Jan 2021 12:00:00 +0000 AtriCure, Inc. News Releases 15151 https://ir.atricure.com/news-releases/news-release-details/atricure-announces-labeling-expansion-cryo-nerve-block-therapy Expansion includes adolescent patients, as young as 12 years of age, who can benefit from cryo nerve block therapy during surgical procedures involving the chest wall. MASON, Ohio --(BUSINESS WIRE)--Jan. 4, 2021-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial Mon, 04 Jan 2021 13:00:00 +0000 AtriCure, Inc. News Releases 15116 https://ir.atricure.com/news-releases/news-release-details/atricure-participate-39th-annual-jp-morgan-healthcare-conference MASON, Ohio --(BUSINESS WIRE)--Dec. 14, 2020-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming 39 th Annual J.P. Mon, 14 Dec 2020 13:00:00 +0000 AtriCure, Inc. News Releases 15086